GI well being platform Vivante Well being secures $31M

Digital gastrointestinal well being firm Vivante Health introduced it closed a $31 million Collection B funding spherical led by new investor Mercato Companions, bringing its whole increase to $47 million.

Well being Catalyst, Intermountain Ventures, SemperVirens, 7wireVentures, Human Capital and Distributed Ventures participated within the spherical. 

WHAT IT DOES

Vivante provides a platform dubbed GIThrive that gives customized care plans. Sufferers can observe their signs and entry instructional content material and self-guided behavioral well being modules. A coordinated group of suppliers can also be accessible through the platform, together with dietitians, coaches and well being physicians.

The Illinois-based firm will use the funding to improve its know-how and develop its workforce.  

“We’re thrilled to have the help of industry-leading capital companions as we execute on our imaginative and prescient at Vivante,” Invoice Snyder, Vivante Well being CEO, mentioned in a press release. “One in 4 Individuals suffers from a digestive dysfunction or undiagnosed digestive signs that have an effect on their high quality of life in addition to their healthcare prices. We have now confirmed that our scalable know-how platform paired with our complete care group ends in higher well being, decrease prices and a a lot better expertise for the members we serve.”

MARKET SNAPSHOT

Vivante raised $16 million in Series A funding final 12 months, $5.8 million in Series A1 investment in 2020 and $6 million in 2018. 

In 2022, Solera Health, a digital platform that gives a market for advantages and persistent illness administration packages, announced it was adding Vivante and fellow digital gastrointestinal well being firm Oshi Health to its market of advantages and persistent care administration instruments. 

Different firms within the digital gastrointestinal house embrace Salvo Health, which provides a digital clinic geared towards individuals with persistent intestine issues similar to irritable bowel syndrome, and Bold Health, a London-based firm growing digital therapeutics for gastrointestinal circumstances.